checkAd

     121  0 Kommentare HealthTab Signs Reseller Agreement With Abbott to Support UK Expansion - Seite 2



    The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery, while empowering patients to take more control of their health. It also reduces costs and waiting times and provides many potential revenue streams including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets, and third-party app integration through API.

    To find a location near you, please visit: healthtab.com/locations

    HealthTab Market Fast Facts

    • Point-of-Care Testing Market to reach $50.6 Billion USD in 2025 (Source)
    • Glucose monitoring (diabetes related) to make up the largest growth within the sector. (Source)
    • Nearly 13.6 Million Canadians expected to diabetic or prediabetic by 2030, with many undiagnosed (Source)
    • Over 1 in 3 Americans, approximately 88 million people, have pre-diabetes (Source)
    • Close to 160,000 Canadians 20 years and older are diagnosed with heart disease each year, often it’s only after a heart attack they are diagnosed. (Source)
    • There are more than 10,000 pharmacies in Canada, 88,000 pharmacies in the US, nearly 12,000 in the UK.

    About Avricore Health Inc.

    Avricore Health Inc. (TSXV: AVCR) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.

    Contact:

    Avricore Health Inc.
    Hector Bremner, CEO 604-773-8943
    info@avricorehealth.com
    www.avricorehealth.com

    Cautionary Note Regarding Forward-Looking Statements
    Information in this press release that involves Avricore Health's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. Avricore Health generally uses words such as "outlook," "will," "could," "would," "might," "remains," "to be," "plans," "believes," "may," "expects," "intends," "anticipates," "estimate," "future," "positioned," "potential," "project," "remain," "scheduled," "set to," "subject to," "upcoming," and similar expressions to help identify forward-looking statements.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    HealthTab Signs Reseller Agreement With Abbott to Support UK Expansion - Seite 2 VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) - Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agreement between HealthTab Inc. and Abbott Rapid Dx …